Latest

Latest CSL News

  • Latest CSL news stories and updates. What is happening today? All recent CSL news and developments. Live coverage and timeline of CSL. All you need to know about CSL.
Brandon Capital Announces Agreement for Novartis to Acquire Portfolio Company Myricx Bio to Advance New Class of Cancer Therapeutics
neffy®, adrenaline nasal spray, now accessible on the Pharmaceutical Benefits Scheme for anaphylaxis
New PBS listing expands access to once-monthly preventive treatment for hereditary angioedema
Adjuvanted flu vaccine, Fluad, approval extended to Australians aged 50 and over
Baker Institute pays tribute to strategic and dedicated leader
Monash University Licences Therapeutic Program To CSL
neffy®, adrenaline nasal spray, now approved to treat anaphylaxis in Australia
Consolidated controlled substance licence requirements published
CSL Workers Unite For 24 Hrs Of Industrial Action
High-tech Vaccine Plant Opens In Melbourne
Qantas Group Appoints New Director
Hume Business Awards celebrate strength of local industry
Australian scientists awarded $2.5 million CSL Centenary Fellowships to advance lifelong immunity research and AI-designed proteins
BioMedTech Incubator Program Delivered By Brandon BioCatalyst’s CUREator And CSIRO Opens New Funding Round
CSL restructure highlights growing uncertainty for exporters
Peter Beattie AC appointed Brandon BioCatalyst Chair
Australian Prime Minister Doorstop interview – Melbourne
If you have a pet as a kid, does this lower your risk of asthma and eczema?
Melbourne hosts Swiss delegation to accelerate innovation through global partnerships
News laws to make it harder for large Australian and foreign companies to avoid paying tax
26 Aussie Scientists Join Best Of Best
Influenza cases already at highest to date with vaccines now available
New Snow Fellow unlocking cancer at the source
PolyNovo Announces Chief Executive Change
5 years since COVID was declared a pandemic, we’re still poorly prepared for the next one
CSL Seqirus secures Australia-NZ rights to commercialise cholesterol-lowering therapy
Immunoglobulin Sales Drive Strong First Half For CSL
Phebra appoints Sarah Elliott as Chief Marketing & Sales Officer
Association between elevated levels of VEGF-B and impaired kidney function
BMW Best in Show at Inaugural Motors & Masterpieces
Investigations into lung cancer and into epigenetics recognised with 2 x $1.25 million CSL Centenary Fellowships
Pharmanovia Acquires Exclusive Rights to Treatment for Parkinson’s Disease
Innovation and industry leaders appointed to STA’s Bench-to-Boardroom Committee
CSL announces sale of Wuhan plasma collection and fractionation operations
AusBiotech 2024 National Conference Programme Unveiled
Jackie Fairley Appointed To Baker Institute Board
CSL Reports Strong Profit Growth For Full Year 2024
Fast Five With Jon Cross
Lupus is more common and severe in Aboriginal and Torres Strait Islander peoples. Learning why is crucial
Bird flu isn’t spreading in humans for now. But there are vaccines in the pipeline if that changes
Dr James Campbell Appointed AusBiotech Chair
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe
AusBiotech and BIO partner to deliver ‘Investing in Australia’ Roundtable at BIO 2024
Supporting Our Nearest Neighbours Through Antivenom Partnership
First approved treatment for people living with moderate-to-severe itch (pruritus) associated with chronic kidney disease added to the PBS
AECOM appoints Heidi Sick to lead its energy and environment team in Australia and New Zealand
UniSC helping to determine next flu vaccine for Southern Hemisphere
Cell & Gene Catalyst submits feedback on HTA consultation

© 2026 - The National Tribune Australia